Current price is more than the intrinsic value

Intrinsic Value

Stock has been generating better return on equity than bank FD

ROE vs FD rates

Stock doesn't offer attractive dividend returns

Dividend Returns

Good time to consider, as stock is not in overbought zone

Entry Point

Stock not in ASM/GSM lists and not a lot of promoter holding is pledged

No Red Flags

PVR shares jumped as the multiplex owner opened its first 12-screen superplex in Kerala; Laurus Labs was up on entering share subscription agreement with Ethan Energy

Why are shares of PVR, Laurus Labs, Indian Hotels & Man Infraconstruction rising today?

Stocks to Watch: Punjab National Bank (PNB) on Thursday said it received the government’s approval to divest its entire stake (15.22 per cent) in UTI Asset Management Company

Stocks to Watch: PNB, Tube Investments, Indian Oil, Laurus Labs, SBI, Lupin

Laurus Labs Ltd is quoting at Rs 466.05, up 2.34% on the day as on 12:49 IST on the NSE. The stock is down 5.09% in last one year as compared to a 1.2% jump in NIFTY and a 7.2% jump in the Nifty Metal index.

Laurus Labs Ltd up for third straight session

Allsec Technologies (Rs 20 per share dividend), Crisil (Rs 10 per share), Navin Fluorine International (Rs 5 per share), Indian Metals & Ferro Alloys (Rs 5 per share), VIP Industries (Rs 2.5 per share), TCI (Rs 2.5 per share) and Vaibhav Global (Rs 1.5 per share) will go ex-dividend today.

Laurus Labs, Coforge, Dabur India to go ex-dividend; stock split, buyback & more

Stocks to watch out for today: Bharti Airtel, L&T, Tata Steel, Vedanta, Maruti Suzuki, Laurus Labs and more

Stocks in news: Bharti Airtel, L&T, Tata Steel, Vedanta and more

The inspection was conducted from October 24, 2022, to October 28, 2022.

Laurus Labs gets one observation from USFDA for pre-approval inspection

Laurus Labs announced that the US FDA has issued Form 483 with one observation after the pre-approval inspection of its Visakhapatnam facility.

Laurus Labs gets Form 483 with 1 observation from USFDA

Here is what the charts say about the shares of HCL Technologies, Jindal Steel & Power and Laurus Labs

Movers & Shakers: Stocks that will see action this week

The company has been issued a Form 483 with one observation. The observation is procedural in nature. The Company will address the observation within stipulated timelines.

Laurus Labs’ Parawada unit undergoes USFDA’s PAI inspection

Custom synthesis business reported strong growth of 365% YoY, 25% QoQ, supported by accelerated demand from new, existing clients.

Laurus Labs Q2 Results Review - Custom Synthesis Outweighs Formulations Decline: ICICI Direct

Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 600 in its research report dated October 25, 2022.

Buy Laurus Labs; target of Rs 600: Sharekhan

Laurus Labs Limited is an India-based pharmaceutical and biotechnology company. The Company is a manufacturer of active pharmaceutical ingredients (API) for antiretroviral (ARV), oncology, cardiovascular, antidiabetics, anti-asthma and gastroenterology. It also develops and manufactures oral solid formulations, which provide contract research and manufacturing services (CRAMS) to other global pharma companies, and produce specialty ingredients for nutraceuticals, dietary supplements and cosmeceuticals. The Company operates through four business units covering a range of therapeutic applications, including Generics API, which is engaged in the development, manufacture and sale of APIs and advanced intermediates; Generics Finished Dosage Form (FDF), which is engaged in the development and manufacture of oral solid formulations; Synthesis, which is a key starting materials, intermediates and APIs for New Chemical Entities (NCEs), and Bio, which is engaged in the recombinant products.

Laurus Labs Ltd

Laurus Labs Ltd

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Why are shares of PVR, Laurus Labs, Indian Hotels & Man Infraconstruction rising today?

Stocks to Watch: PNB, Tube Investments, Indian Oil, Laurus Labs, SBI, Lupin

Laurus Labs Ltd up for third straight session

Laurus Labs, Coforge, Dabur India to go ex-dividend; stock split, buyback & more

Stocks in news: Bharti Airtel, L&T, Tata Steel, Vedanta and more

Laurus Labs gets one observation from USFDA for pre-approval inspection

Laurus Labs gets Form 483 with 1 observation from USFDA

Movers & Shakers: Stocks that will see action this week

Laurus Labs’ Parawada unit undergoes USFDA’s PAI inspection

Laurus Labs Ltd

Intrinsic ValueIntrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD ratesFixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend ReturnsA dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry PointHigh demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock

News & Opinions

Why are shares of PVR, Laurus Labs, Indian Hotels & Man Infraconstruction rising today?

Stocks to Watch: PNB, Tube Investments, Indian Oil, Laurus Labs, SBI, Lupin

Laurus Labs Ltd up for third straight session

Laurus Labs, Coforge, Dabur India to go ex-dividend; stock split, buyback & more

Stocks in news: Bharti Airtel, L&T, Tata Steel, Vedanta and more

Laurus Labs gets one observation from USFDA for pre-approval inspection

Laurus Labs gets Form 483 with 1 observation from USFDA

Movers & Shakers: Stocks that will see action this week

Laurus Labs’ Parawada unit undergoes USFDA’s PAI inspection

Intrinsic Value
Intrinsic value is the calculated value of the company and may differ from current stock price. If intrinsic value > current price, price increase is expected in the future to reduce the gap and vice-versa

ROE vs FD rates
Fixed Deposit rate is a virtually risk-free rate where the investor assumes almost no risk on their investment. If stock's long term average ROE is lower than this rate, investors are better off investing the amount in a FD

Dividend Returns
A dividend is the distribution of reward from a portion of company's earnings and is paid to its shareholders. Good dividend returns indicate good health and outlook for the company

Entry Point
High demand for a stock increases its price. If the price is pushed up to a level which is not justified, then it's considered to be in the overbought zone, which is not a good time to buy the stock